Medicare Price Negotiation Round Two: New Administration, More Drugs, Less Time

 
• By Cathy Kelly
  
Manufacturers targeted by the price negotiation process have little time to decide whether to participate. (Shutterstock)

More from Drug Pricing

More from Scrip